Extracorporeal Membrane Oxygenation for COVID-19: Case Report of Nine Patients

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Covid-19, Coronavirus disease 2019; ARDS, Acute respiratory distress syndrome; ECMO, Extracorporeal Membrane Oxygenation; WHO, World Health Organization; ICUs, Intensive care units. Acute respiratory distress syndrome (ARDS) is a fatal comorbidity of critically ill patients with COVID-19, who often end up on respiratory support. However, the safety and effectiveness of Extracorporeal Membrane Oxygenation (ECMO) in the treatment of COVID-19 remains to be elucidated at present. Here, we report on nine patients who received ECMO due to severe SARS-CoV-2 infection in Wuhan, China. Our initial experiences suggest that carefully selecting patients, as well as management by a well-trained team, are critical to implementing ECMO in patients with COVID-19. More randomized controlled trials with larger sample sizes are needed to evaluate the usefulness of ECMO in patients with COVID-19.

Cite

CITATION STYLE

APA

Hua, J., Zhang, X., Wang, N., Ran, L., Wang, S., Huang, C., … Wang, F. (2021). Extracorporeal Membrane Oxygenation for COVID-19: Case Report of Nine Patients. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.697338

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free